Semetron - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2021-04-30
|
2021
From: 2021-05-01
To: 2022-04-30
|
2022
From: 2022-05-01
To: 2023-04-30
|
2023
From: 2023-05-01
To: 2024-04-30
|
2024
From: 2024-05-01
To: 2025-04-30
|
2025
From: 2025-05-01
To: 2026-04-30
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 894,735 | 486,932 | 172,603 | 121,242 | 83,945 | 123,948 | 1,227,299 | 1,516,980 |
| Profit before tax | 69,353 | 2,274 | -41,722 | -42,728 | -56,901 | -135,679 | -132,248 | -83,807 |
| Net profit | 66,225 | 1,906 | -41,722 | -42,728 | -56,901 | -135,679 | -132,248 | -83,807 |
| Equity | 70,240 | 72,146 | 30,423 | -12,304 | -69,205 | -14,945 | -147,193 | -231,000 |
| Liabilities | 410,061 | 8,726 | 9,846 | 35,907 | 91,540 | 45,361 | 774,939 | 686,144 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 246,625 | 186,934 |
| Current assets | 480,301 | 55,832 | 40,269 | 23,603 | 22,067 | 30,416 | 381,121 | 267,610 |
| Total assets | 480,301 | 55,832 | 40,269 | 23,603 | 22,067 | 30,416 | 627,746 | 454,544 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 21,000 | 55,246 | 77,452 |
| Social insurance contributions | - | - | - | - | - | - | 36,412 | 53,153 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +3221.8% | -45.6% | -64.6% | -29.8% | -30.8% | +47.7% | +890.2% | +23.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 13.8% | 3.4% | -103.6% | -181.0% | -257.9% | -446.1% | -21.1% | -18.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 94.3% | 2.6% | -137.1% | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.4% | 0.4% | -24.2% | -35.2% | -67.8% | -109.5% | -10.8% | -5.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.8% | 0.5% | -24.2% | -35.2% | -67.8% | -109.5% | -10.8% | -5.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 5.8 | 0.1 | 0.3 | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 290,187 | 292,153 | 86,302 | 85,581 | 53,019 | 59,496 | 320,168 | 308,536 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Semetron - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-06-17 | 3460.87 |
| 2026-05-17 | 2026-05-17 | 3429.03 |
| 2025-10-16 | 2025-10-16 | 4394.49 |
| 2024-11-18 | 2024-11-19 | 4200.34 |
| 2024-07-16 | 2024-07-16 | 7071.89 |
| 2024-03-18 | 2024-03-18 | 3242.01 |
| 2024-02-19 | 2024-02-19 | 2583.51 |
| 2024-01-16 | 2024-01-16 | 2407.66 |
| 2023-12-18 | 2023-12-18 | 2089.98 |
| 2023-09-19 | 2023-09-25 | 13.82 |
| 2023-09-18 | 2023-09-18 | 954.09 |
| 2023-06-16 | 2023-06-20 | 933.37 |
Semetron - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-11-06 | 2025-11-24 | 3.47 |
| 2025-11-02 | 2025-11-05 | 1741.75 |
| 2025-10-30 | 2025-11-01 | 2038.53 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Semetron, UAB (code 304036356) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 1.52 million in revenue, up 23.6% year on year, after EUR 1.23 million in 2024 and EUR 123.9 thousand in 2023. The three-year trajectory shows very strong sales expansion, although profitability remained negative throughout the period. Net loss narrowed in relative terms from a margin of -10.8% in 2024 to -5.5% in 2025, with net profit at -EUR 83.8 thousand in 2025 versus -EUR 132.2 thousand in 2024 and -EUR 135.7 thousand in 2023. On the balance sheet, total assets declined to EUR 454.5 thousand in 2025 from EUR 627.7 thousand a year earlier, while liabilities stood at EUR 686.1 thousand and equity remained negative at EUR 231.0 thousand. Asset turnover was 3.34x, indicating strong revenue generation relative to assets. Revenue per employee reached EUR 379.2 thousand, while profit per employee was negative at EUR 21.0 thousand. Equity-based profitability and leverage ratios should be interpreted cautiously given the negative equity position.